Family Medicine · Northern Cambria, PA
NPI
1629089982
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
1704 Philadelphia Ave
Northern Cambria, PA, 15714
Phone (814) 948-0775
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
2,295 services
Medicare patients, 2024
96
Average age 64
Drug cost, 2024
$1.2M
11,600 prescriptions
Company payments, 2025
$945
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Vasil was code 95004 (test - miscellaneous), 981 times for 14 patients. In total John M Vasil billed 2,295 services in 40 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 981 | 14 | $2.65 | $2,602 |
| 99214 Office E&M - Established | Office | 304 | 83 | $81.51 | $25K |
| 99213 Office E&M - Established | Office | 194 | 66 | $58.80 | $11K |
| 81002 Clinical Chemistry | Office | 89 | 45 | $3.41 | $303 |
| 99443 Telephone Services | Office | 59 | 33 | $91.88 | $5,421 |
| 80305 Drug Tests | Office | 58 | 18 | $12.35 | $716 |
| 36415 Venipuncture Blood Collection | Office | 57 | 40 | $4.90 | $279 |
| 85014 Blood Count | Office | 47 | 16 | $2.32 | $109 |
| 85018 Blood Count | Office | 47 | 16 | $2.32 | $109 |
| 82962 Clinical Chemistry | Office | 47 | 16 | $3.21 | $151 |
| 83036 Blood Count | Office | 43 | 16 | $9.52 | $409 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 37 | 37 | $119.32 | $4,415 |
| G0008 Administration of influenza virus vaccine | Office | 35 | 34 | $30.77 | $1,077 |
| 90661 Vaccine Product | Office | 35 | 34 | $36.11 | $1,264 |
By year: 2022 $62K for 3,040 services; 2023 $63K for 2,099 services; 2024 $64K for 2,295 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 89 | 45 | $3.41 | $303 |
| 80305 Drug Tests | 58 | 18 | $12.35 | $716 |
| 36415 Venipuncture Blood Collection | 57 | 40 | $4.90 | $279 |
| 82962 Clinical Chemistry | 47 | 16 | $3.21 | $151 |
| 85018 Blood Count | 47 | 16 | $2.32 | $109 |
| 85014 Blood Count | 47 | 16 | $2.32 | $109 |
| 83036 Blood Count | 43 | 16 | $9.52 | $409 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Vasil prescribed most often to Medicare patients was Amlodipine Besylate, with 442 prescriptions and refills. In total John M Vasil wrote 11,600 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 442 | 704 | 70 | $2,059 |
| Atorvastatin Calcium Generic | 417 | 658 | 71 | $2,969 |
| Lisinopril Generic | 403 | 677 | 69 | $2,314 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 367 | 367 | 117 | $43K |
| Simvastatin Generic | 355 | 663 | 64 | $3,510 |
| Potassium Chloride Generic | 327 | 467 | 58 | $4,710 |
| Levothyroxine Sodium Generic | 306 | 440 | 43 | $2,885 |
| Furosemide Generic | 302 | 388 | 50 | $1,411 |
| Pantoprazole Sodium Generic | 292 | 409 | 46 | $2,384 |
| Metformin Hcl Generic | 284 | 493 | 54 | $1,905 |
| Metoprolol Succinate Generic | 282 | 539 | 56 | $4,017 |
| Glipizide Er Glipizide | 213 | 355 | 34 | $3,756 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 196 | 196 | 32 | $2,691 |
| Omeprazole Generic | 194 | 294 | 34 | $2,764 |
| Tamsulosin Hcl Generic | 177 | 251 | 28 | $2,267 |
Brand drugs: 1,334 claims; generic drugs: 10,190 claims; opioid claims: 414.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Vasil $945 ($945 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novo Nordisk Inc with $255.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $255 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $153 |
| GlaxoSmithKline, LLC. GSK | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71.55 |
| Exact Sciences Corporation EXAS | 3 | $49.74 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $47.93 |
| Abbvie Inc. ABBV | 2 | $46.56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $44.56 |
| Lilly USA, LLC LLY | 2 | $38.31 |
| Paratek Pharmaceuticals, Inc. | 1 | $27.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.